Caninsulin: Intervet's U40 pork lente insulin--this is its name in most of the world.
Vetsulin-Intervet's US name for its U40 pork lente insulin.
Headquartered in the Netherlands, Intervet, [1] founded in 1969, has a global presence. It was the third-largest veterinary pharmaceutical company in the world. There are Intervet products to help almost every species--from birds to farm animals and horses. The company has been well-known for its work in veterinary vaccines and other platforms. It is best-known to us with diabetic pets as the producer of Caninsulin (known in some countries as Vetsulin), a U40 porcine Lente insulin.
Owned by Akzo-Nobel, Intervet was one of the three companies that made up Akzo-Nobel's pharmaceutical division. [2] Completing the division are Organon, a human pharmaceutical company (its first product was insulin in 1923), [3][4] and Diosynth, which makes biotech and traditional pharmaceutical raw materials (among them, insulin extracted from animal pancreases since 1923). [5][6][7][8]
Intervet merged with Schering-Plough Animal Health; both companies have now merged with Merck. The Merck merger created the second-largest veterinary pharmaceutical company in the world.[9] On June 29, 2011, it was announced that Intervet/Schering-Plough Animal Health would now be known as Merck Animal Health in the United States and Canada and called MSD Animal Health elsewhere.[10]
References[]
- ↑ Intervet International Website
- ↑ Akzo Nobel-Companies. Akzo-Nobel (2005).
- ↑ Organon International History-1920-Products. Organon.
- ↑ Report on Insulin in Europe-Insulin Committee-page 26. University of Toronto (1925).
- ↑ Diosynth & Biochemistry. Diosynth.
- ↑ Diosynth Products and Technology-Page 3. Diosynth.
- ↑ Diosynth Company History. Diosynth.
- ↑ Diosynth France, Usine Saint Charles-Extraction Plant for insulin.
- ↑ Intervet/Schering-Plough, Merial Call Off Merger. DVM360 (23 March 2011).
- ↑ Merck Announces New Name For Its Animal Health Division (29 June 2011).
All items (1)